Analyst Ratings for Moonlake Immunotherapeutics (MLTX)
MLTX Rating Summary
MLTX Price Target Summary
- Highest: $80.00 (Wedbush)
- Lowest: $5.00 (Citi)
- Average: $29.54
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$29.54 (+62.7%)
* Over Last 12-Mos
Rating Score: 6.1 / 10
Percentile Rank: 65%
Rating Score: 6.1 / 10
Percentile Rank: 65%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/15/2026 | Goldman Sachs | Richard Law | Downgrade | Sell (Neutral) |
10.00 (8.00) |
17.10 (18.15) |
6.14% | Details |
| 1/9/2026 | BTIG » Updated 2/9/2026 |
Julian Harrison | Upgrade | Buy (Neutral) |
24.00 (N/A) |
14.34 (18.15) |
26.57% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
